High Rate of Percutaneous Gastrostomy Placement in COVID-19 Patients With Low Overall Complications
Tech Innov Gastrointest Endosc
.
2021;23(4):385-387.
doi: 10.1016/j.tige.2021.07.001.
Epub 2021 Jul 7.
Authors
Megan Lipcsey
1
,
Daniel J Stein
2
,
Rosa L Yu
3
,
Rajsavi Anand
3
,
Mohammad Bilal
4
,
Akiva Leibowitz
5
,
Mandeep Sawhney
6
,
Joseph D Feuerstein
6
Affiliations
1
Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
2
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.
3
Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, Massachusetts.
4
Department of Gastroenterology, University of Minnesota Minneapolis VA Medical Center, Minneapolis, Minnesota.
5
Department of Anesthesiology, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
6
Division of Gastroenterology, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, Minnesota.
PMID:
34250514
PMCID:
PMC8262403
DOI:
10.1016/j.tige.2021.07.001
No abstract available
Keywords:
COVID-19; Coronavirus; PEG; PEG adverse events; Percutaneous endoscopic gastrostomy.